Notícias · Recifes

After weight loss, exercise improves cardiovascular health more than weight-loss medicatio

People with severe obesity who exercise regularly have healthier blood vessels and lower inflammation than those who rely on medication alone, a new study from the University of Copenhagen shows.

Admin Recifes 15/07/2026 1

Most obesity drugs do not improve quality of life or heart health, analysis indicates

Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence published by The BMJ.

Admin Recifes 15/07/2026 1

GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula

Admin Recifes 15/07/2026 2

New treatment helps achieve a healthier BMI in people with weight dysregulation after brai

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers h

Admin Recifes 15/07/2026 1

Psilocybin therapy shows potential as a treatment for anorexia nervosa in small trial

A small pilot study from the Center for Psychedelic Research at Imperial College London indicates that psilocybin—the active ingredient in psychedelic "magic mushrooms"—may have potential as a treatment for anorexia nervosa when combined with therapy. Anorexia nervosa is a seriou

Admin Recifes 15/07/2026 1

Societies combine to issue recommendations on use of incretin drugs in obesity therapy

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the

Admin Recifes 15/07/2026 1

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. O recorte ajuda a contextualizar a pauta dentro de Fitness.

Admin Recifes 15/07/2026 1

Weight‑loss jabs may create a new kind of yo‑yo dieting

For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Moun

Admin Recifes 15/07/2026 1

Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The

Admin Recifes 15/07/2026 1

Knowledge about genes isn't enough: How to inform people about genetic risk of obesity

Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study published in the journal Obesity Reviews by scientists, including researchers from SWPS University, shows that knowledge about one's genes alone is not enough.

Admin Recifes 15/07/2026 1

Study shows promising outcomes for bariatric surgery in adolescents and young adults with

A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute demonstrates that metabolic and bariatric surgery can be delivered safely and effectively for adolescents and young adults

Admin Recifes 15/07/2026 1

Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop

Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential treatment strategy that combines popular weight-lo

Admin Recifes 15/07/2026 1

Acompanhe as Notícias da Recifes